CPHC director granted 2,547 deferred shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Chronister Mark reported acquisition or exercise transactions in this Form 4 filing.
Canterbury Park Holding Corp director Mark Chronister received a deferred stock award of 2,547 shares of common stock. The award vests at the company’s 2027 annual meeting of shareholders and will not be delivered until one year after vesting. The number of shares was based on the closing price of $15.70 on June 4, 2026. Following this grant, Chronister directly holds 13,528 shares of common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 2,547 | $0.00 | $0.00 |
Footnotes (1)
- F1. Deferred stock award vesting at the Company's 2027 Annual Meeting of Shareholders, but not delivered until one year from the vesting date. The number of shares to be issued was determined based on the closing price of $15.70 as of June 4, 2026.
Key Figures
Key Terms
Deferred stock award financial
vesting financial
closing price financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did CPHC director Mark Chronister report on this Form 4?
When does Mark Chronister’s CPHC deferred stock award vest and settle?
AI-generated analysis. How Rhea-AI works. Not financial advice.